Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unboosted vs. Boosted Reyataz Maintenance in HIV (INDUMA)
NCT00207142Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 4 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Nov 2005; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00207142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00207142.